Figure 6.
Schematic depiction of plausible mechanisms underlying the protective effect of metformin against hyperglycaemia-induced vascular fibrosis. Metformin inhibits TGF-β1/SMAD2/3 signalling to inhibit DDR2-dependent pro-fibrotic gene expression in HG-stimulated vascular adventitial fibroblasts.